Skip to content

Use of SMS services to improve Tuberculosis treatment completion

Use of SMS services to improve Tuberculosis treatment completion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201310000671259
Enrollment
582
Registered
2013-10-07
Start date
2010-10-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS Tuberculosis

Interventions

SMS awareness and reminder service
none

Sponsors

Yukari Manabe
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Age ¿ 18 years Informed consent Newly diagnosed active tuberculosis, as defined by the current WHO guidelines (26), for which TB treatment will be initiated or has been initiated in the two weeks prior to the screening for eligibility Ownership of or sufficient access to a mobile phone (shared access will be allowed if access is daily, patients have disclosed or are willing to disclose their TB status to the phone owner and/or any other users of the phone, and the phone owner agrees to participate) Demonstrated ability to sufficiently operate a cell phone to communicate using textmessaging, assessed by typing and sending a sample text message at enrolment Literacy (for illiterate patients who have disclosed or are willing to disclose their TB status help by a treatment buddy will be sufficient) Willingness and ability to comply with study procedures.

Exclusion criteria

Exclusion criteria: Any specific condition that in the judgment of the investigator precludes participation because it could affect a participant¿s safety. For the historical control group: no mobile phone number recorded at treatment initiation

Design outcomes

Primary

MeasureTime frame
TB treatment default

Secondary

MeasureTime frame
Proportion of patients who undergo a repeat sputum;TB drug adherence (expressed in percentages of pills taken);ART adherence (expressed in percentages of pills taken);Clinic attendance, expressed as number of missed;Patients¿ satisfaction and knowledge on TB/HIV issues;Cost-effectiveness

Countries

Uganda

Contacts

Public ContactSabine Hermans

post-doctoral researcher

s.hermans@aighd.org+27726940945

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026